FDA inspection
SRI Krishna Pharmaceuticals Ltd: FDA inspection ending May 15, 2015
FDA inspection 928508 · No Action Indicated (NAI) · Hyderabad
Key facts
| Inspection ID | 928508 |
|---|---|
| Firm | SRI Krishna Pharmaceuticals Ltd |
| FEI number | 3003723117 |
| Address | C-4 Industrial Development Area, Uppal Khalsa, Uppal Mandal, Medchal-Malkajgi |
| City | Hyderabad |
| Country | India |
| Fiscal year | 2015 |
| Inspection end date | May 15, 2015 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data